Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38209

Atp6v0a1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The ATP6V0A1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population lacking vacuolar ATPase subunit a1. This model enables study of lysosomal acidification, autophagy, mTOR, and Wnt signaling, implicated in osteopetrosis, neurodegeneration, and cancer, involving regulators MITF/TFEB, effectors mTORC1/??-catenin, and interactors like LRP5/6. Loss-of-function studies are supported by LysoTracker staining, LC3 immunofluorescence, phospho-S6K western blot, and Wnt reporter assays. The polyclonal format offers a robust population tool for pH-dependent cellular studies and screening V-ATPase pathway modulators.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ATP6V0A1

    Gene Identifier

    NCBI Gene ID 535

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ATP6V0A1 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-engineered polyclonal knockout cell population targeting the ATP6V0A1 gene. This product provides a heterogeneous mixture of HEK293T cells with disrupted expression of the a1 isoform of vacuolar ATPase (V-ATPase) V0 subunit, a critical component of the proton translocation machinery. The polyclonal format avoids clonal biases, offering a robust tool for investigating V-ATPase-dependent acidification, membrane trafficking, and signaling pathways in a population-averaged context.

The host cell line, HEK293T, is an immortalized human embryonic kidney epithelial line expressing SV40 large T antigen. Widely used for protein expression, viral production, and signal transduction studies, HEK293T cells exhibit high transfection efficiency and rapid growth. Their kidney epithelial origin provides a physiologically relevant system for examining ion homeostasis and organelle acidification, where V-ATPase function is essential. Stable expression of SV40 large T antigen enhances episomal replication of plasmids containing the SV40 origin, making these cells particularly suitable for transient overexpression or complementation experiments.

ATP6V0A1 encodes the a1 subunit of the V-ATPase V0 domain, which forms the proton pore. V-ATPase activity acidifies lysosomes, endosomes, and autolysosomes, facilitating autophagy and cargo degradation. Upstream regulators MITF and TFEB promote ATP6V0A1 transcription under nutrient stress, while mTORC1 senses V-ATPase function at the lysosomal membrane via RAG GTPases. V-ATPase also interacts with LRP5/6 to modulate Wnt signalosome assembly and ??-catenin stabilization. Consequently, ATP6V0A1 disruption impairs lysosomal hydrolase activity, mTORC1 signaling, and Wnt pathway output, linking nutrient sensing to cellular growth and differentiation.

In HEK293T cells, loss of ATP6V0A1 results in a phenotype measurable by standard assays. Reduced LysoTracker staining confirms impaired lysosomal acidification, while increased LC3 puncta indicate defective autophagy. Attenuated mTORC1 activity is detected by decreased phospho-S6K western blot, and altered Wnt signaling is assessed via TOPFlash/FOPFlash luciferase reporters. The polyclonal knockout population is ideal for bulk biochemical experiments and pooled screens, as it averages out clonal variation and avoids single-clone artifacts.

This model is applicable to research on lysosomal storage disorders, neurodegeneration, and cancer, where dysregulated V-ATPase and autophagy are key. Osteoclast function studies benefit from ATP6V0A1’s role in acidifying the resorption lacuna, relevant to infantile malignant osteopetrosis. The intersection of V-ATPase with mTOR and Wnt pathways makes these cells useful for drug discovery screening of autophagy modulators or Wnt inhibitors. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)